In COPD, patient initiation and persistent use of guideline-concordant maintenance inhaled medications is subpar.

Columnist Sam Kirton talks to Scott Staszak, president and CEO of the Pulmonary Fibrosis Foundation, about the need for better research.

Who helps you manage your COPD? It’s more than just one doctor. It’s a medical care team. What Kind of Doctors Treat COPD? Your COPD care team includes providers who prescribe medicine, guide therapy ...

Medicare Part D provides prescription drug coverage for beneficiaries to support their pharmacological treatment; however, the complex deductible structure within benefit plans creates a major ...

Many patients who have excess mucous production experience complicating bronchiectasis, which can be documented by high-resolution computed tomography (CT) of the chest. In the past, patients who had ...

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant variant of alpha-1 antitrypsin (AAT) within hepatocytes, which limits its ...